The UK government’s National Institute of Health Research (NIHR) has recently agreed to fund a new study to compare a gradual and supported programme of antipsychotic reduction with maintenance treatment. The RADAR research programme (Research into Antipsychotic Discontinuation And Reduction) has just started.
Moncrieff is known to be strongly anti/critical of the use of medication.
I think it’s a good idea for people who are not benefiting from their APs and need help tapering off of them. Not everyone benefits from APs, and there is not much point in suffering the side effects if the medication isn’t even helping you. Hopefully they are able to take care in determining the difference between a candidate who is not benefiting, and a candidate who does not realize they are benefiting.